Uranium Royalty Corp. (UROY) files 6-K with equity deal and consents

Rhea-AI Filing Summary

Uranium Royalty Corp. furnished a Form 6-K for August 2025 that mainly updates investors through several attached exhibits. These include a press release, a material change report, and an Equity Distribution Agreement, all dated August 20, 2025, plus legal consents from three law firms.

Certain exhibits (99.2 through 99.6) are incorporated by reference into the company’s Form F-10 registration statement, meaning they now legally form part of that offering document. The report is signed on behalf of the company by Chief Financial Officer Andrew Marshall.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

UNDER the Securities Exchange Act of 1934

For the month of August 2025

Commission File No.: 001-40359

Uranium Royalty Corp.

(Translation of registrant’s name into English)

Suite 1830, 1188 West Georgia Street

Vancouver, British Columbia, V6E 4A2, Canada

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☐ Form 40-F ☒

INCORPORATION BY REFERENCE

Exhibits 99.2 through 99.6 contained in this Form 6-K shall be deemed to be incorporated by reference into the registration statement on Form F-10, as amended (Registration No. 333-288789) of the Company (including any prospectuses forming a part of such registration statements) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Uranium Royalty Corp.
Date: August 20, 2025	By:	/s/ Andrew Marshall
	Name:	Andrew Marshall
	Title:	Chief Financial Officer

EXHIBIT INDEX

Exhibit		Description of Exhibit
99.1		Press Release dated August 20, 2025
99.2		Material Change Report dated August 20, 2025
99.3		Equity Distribution Agreement dated August 20, 2025
99.4		Consent of Sangra Moller LLP
99.5		Consent of Borden Ladner Gervais LLP
99.6		Consent of Darcy Hirsekorn

FAQ

What does Uranium Royalty Corp. (UROY) disclose in this August 2025 Form 6-K?

Uranium Royalty Corp. provides a Form 6-K that mainly furnishes exhibits dated August 20, 2025. These include a press release, a material change report, an Equity Distribution Agreement, and several legal consents that together update and supplement its existing disclosure record.

What is the purpose of the Equity Distribution Agreement mentioned by Uranium Royalty Corp. (UROY)?

The Equity Distribution Agreement is a key exhibit dated August 20, 2025. While specific terms are not described here, its inclusion signals a formal arrangement related to equity distribution, which becomes part of the company’s regulatory record through this Form 6-K filing.

How are Uranium Royalty Corp. (UROY) exhibits incorporated by reference into Form F-10?

Exhibits 99.2 through 99.6 are incorporated by reference into Uranium Royalty Corp.’s Form F-10 registration statement. This means those documents are legally treated as part of the Form F-10, enhancing the disclosure available to investors relying on that registration.

Which exhibits are attached to Uranium Royalty Corp.’s August 20, 2025 Form 6-K?

The filing lists six exhibits: a press release, a material change report, the Equity Distribution Agreement, and three separate legal consents from Sangra Moller LLP, Borden Ladner Gervais LLP, and Darcy Hirsekorn, all dated August 20, 2025 and referenced in the 6-K.

Who signed Uranium Royalty Corp. (UROY)’s August 2025 Form 6-K and in what capacity?

The Form 6-K is signed by Andrew Marshall on behalf of Uranium Royalty Corp. He signs in his capacity as Chief Financial Officer, confirming the company has duly caused the report to be filed pursuant to the Securities Exchange Act of 1934 requirements.

What is the significance of the legal consents included in Uranium Royalty Corp.’s Form 6-K?

Three legal consents are included as exhibits from Sangra Moller LLP, Borden Ladner Gervais LLP, and Darcy Hirsekorn. These consents allow their opinions or involvement to be used in connection with the company’s registration statement and related disclosure documents incorporated by reference.